BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 28265685)

  • 21. Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study.
    de Boer HD; Driessen JJ; Marcus MA; Kerkkamp H; Heeringa M; Klimek M
    Anesthesiology; 2007 Aug; 107(2):239-44. PubMed ID: 17667567
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prolonged residual paralysis after a single intubating dose of rocuronium: an unexpected cause].
    Guerci P; Vial F; Raft J; Meistelman C; Bouaziz H
    Ann Fr Anesth Reanim; 2012; 31(7-8):632-4. PubMed ID: 22763308
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rocuronium 0.3 mg x kg-1 (ED95) induces a normal peak effect but an altered time course of neuromuscular block in patients with Duchenne's muscular dystrophy.
    Muenster T; Schmidt J; Wick S; Forst J; Schmitt HJ
    Paediatr Anaesth; 2006 Aug; 16(8):840-5. PubMed ID: 16884467
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Failure of neuromuscular blockade reversal after rocuronium in a patient who received oral neomycin.
    Hasfurther DL; Bailey PL
    Can J Anaesth; 1996 Jun; 43(6):617-20. PubMed ID: 8773869
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of sugammadex on incidence of postoperative residual neuromuscular blockade: a randomized, controlled study.
    Brueckmann B; Sasaki N; Grobara P; Li MK; Woo T; de Bie J; Maktabi M; Lee J; Kwo J; Pino R; Sabouri AS; McGovern F; Staehr-Rye AK; Eikermann M
    Br J Anaesth; 2015 Nov; 115(5):743-51. PubMed ID: 25935840
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction with sevoflurane-remifentanil is comparable to propofol-fentanyl-rocuronium in PONV after laparoscopic surgery.
    Yang H; Choi PT; McChesney J; Buckley N
    Can J Anaesth; 2004; 51(7):660-7. PubMed ID: 15310632
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reversal of neuromuscular blockade by sugammadex after continuous infusion of rocuronium in patients randomized to sevoflurane or propofol maintenance anesthesia.
    Rex C; Wagner S; Spies C; Scholz J; Rietbergen H; Heeringa M; Wulf H
    Anesthesiology; 2009 Jul; 111(1):30-5. PubMed ID: 19512873
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Influence of neostigmine on the course of neuromuscular blockade with rocuronium or cisatracurium: a randomized, double-blind trial].
    Barrio J; San Miguel G; García V; Pelegrín F
    Rev Esp Anestesiol Reanim; 2007; 54(7):399-404. PubMed ID: 17953333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reversal of neuromuscular blockade by sugammadex in laparoscopic bariatric surgery: In support of dose reduction.
    Badaoui R; Cabaret A; Alami Y; Zogheib E; Popov I; Lorne E; Dupont H
    Anaesth Crit Care Pain Med; 2016 Feb; 35(1):25-29. PubMed ID: 26597732
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prolonged neuromuscular blockade associated with rocuronium.
    Lewis KS; Santucci VN; Normoyle DL; Rothenberg DM
    Am J Health Syst Pharm; 1999 Jun; 56(11):1114-8. PubMed ID: 10385459
    [No Abstract]   [Full Text] [Related]  

  • 31. The effects of neuromuscular blockade on operating conditions during general anesthesia for spinal surgery.
    Li YL; Liu YL; Xu CM; Lv XH; Wan ZH
    J Neurosurg Anesthesiol; 2014 Jan; 26(1):45-9. PubMed ID: 23887680
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuromuscular blocking effects of rocuronium during desflurane, isoflurane, and sevoflurane anaesthesia.
    Wulf H; Ledowski T; Linstedt U; Proppe D; Sitzlack D
    Can J Anaesth; 1998 Jun; 45(6):526-32. PubMed ID: 9669005
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Significantly prolonged neuromuscular blockade after a single dose of rocuronium: The importance of monitoring.
    Soares M; Esteves S
    Eur J Anaesthesiol; 2016 Sep; 33(9):693-4. PubMed ID: 27136491
    [No Abstract]   [Full Text] [Related]  

  • 34. Sugammadex in anesthesia practice.
    Duvaldestin P; Plaud B
    Expert Opin Pharmacother; 2010 Nov; 11(16):2759-71. PubMed ID: 20977408
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intubating conditions and neuromuscular block after divided dose mivacurium or single dose rocuronium.
    Patel N; Kamath N; Smith CE; Pinchak AC; Hagen JH
    Can J Anaesth; 1997 Jan; 44(1):49-53. PubMed ID: 8988824
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reversal of prolonged rocuronium neuromuscular blockade with sugammadex in an obstetric patient with transverse myelitis.
    Weekes G; Hayes N; Bowen M
    Int J Obstet Anesth; 2010 Jul; 19(3):333-6. PubMed ID: 20627694
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Indications and clinical use of sugammadex].
    Debaene B; Meistelman C
    Ann Fr Anesth Reanim; 2009 Sep; 28 Suppl 2():S57-63. PubMed ID: 19887279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rocuronium pharmacokinetic-pharmacodynamic relationship under stable propofol or isoflurane anesthesia.
    Dragne A; Varin F; Plaud B; Donati F
    Can J Anaesth; 2002 Apr; 49(4):353-60. PubMed ID: 11927473
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of sugammadex for the reversal of moderate and deep rocuronium-induced neuromuscular block in patients pretreated with intravenous magnesium: a randomized controlled trial.
    Czarnetzki C; Tassonyi E; Lysakowski C; Elia N; Tramèr MR
    Anesthesiology; 2014 Jul; 121(1):59-67. PubMed ID: 24608361
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Sugammadex: something new to improve patient safety or simply a gadget?].
    Plaud B
    Ann Fr Anesth Reanim; 2009 Sep; 28 Suppl 2():S64-9. PubMed ID: 19887280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.